Return to Clinical Trials Search Results
ORACLE Registry Dr. Biswas Biodesix Nodify XL2
Primary Outcome Measures :
Statistically significant change in the proportion of benign lung nodules managed by BDX-XL2 experiencing invasive procedures. [ Time Frame: Up to 2 years ]
Primary Outcome Measures :
Statistically significant change in the proportion of benign lung nodules managed by BDX-XL2 experiencing invasive procedures. [ Time Frame: Up to 2 years ]
Recruitment Status
Past Studies